Rene Russo's Net Worth

$0

Estimate Recalculated Nov 1, 2024 04:18AM EST

Who is Rene Russo?

Rene Russo does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Adagio Therapeutics, Inc., Xilio Therapeutics, Inc., and Arsanis, Inc..

SEC CIK

Rene Russo's CIK is 0001722066

Past Insider Trading and Trends

2021 was Rene Russo's most active year for acquiring shares with 5 total transactions. Rene Russo's most active month to acquire stocks was the month of May. 2021 saw Rene Russo paying a total of $57,000.00 for 291,634 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Adagio Therapeutics, Inc. (IVVD) Snapshot price: $0.822

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 5
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844

PRESIDENT AND CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 1
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Aug 16
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Feb 22
Form 4/A
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Dec 22
Form 4
—
0
—
—
0
Oct 21
Form 3
—
0
—
—
0
No matching records found

Arsanis, Inc. (XFOR) Snapshot price: $0.6887

President and CEO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 2
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 17
Form 4
—
0
—
—
0
Mar 7
Form 3
—
0
—
—
0
No matching records found